Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. GI Dynamics taps medtech vet Schorer for CEO
GI Dynamics said this week that it named a veteran medical device executive, Scott Schorer, to be its new president & CEO effective immediately.
Schorer spent the last 6 years as a consultant, advising and helping run companies including stealthy Auris Robotics and Neograft Technologies, and led sales improvement efforts at Medtronic, Zimmer Biomet, Covidien, Teleflex and Stryker. Read more
4. Report: Olympus hiked the price on ‘scopes during superbug outbreak
Olympus reportedly tried to hike the price on the duodenoscopes implicated in superbug outbreaks last year even as the infections were traced back to its own devices.
As the outbreak at UCLA’s Ronald Reagan hospital was linked to the Olympus duodenoscopes and the devices were taken out of service, the hospital asked Olympus for replacements, according to the Los Angeles Times. Olympus responded by raising the price by 28% over what it had charged months earlier, the Times reported, citing UCLA emails obtained from a public-records request. Read more
3. Goldman Sachs gets in on Chinese cardiac valve maker Venus Medtech
Chinese replacement heart valve maker Venus Medtech said today that it won a $37 million commitment from Goldman Sachs.
Hangzhou-based Venus said it’s also won backing from Qiming Venture Partners, Sequoia Capital China, and Dinova Venture Capital. The company already has a transcatheter aortic valve replacement on the market in the People’s Republic and said a pulmonary valve is in clinical trials. Read more
2. TransEnterix pushes Surgibot decision date back
TransEnterix yesterday said the FDA isn’t finished reviewing the 510(k) application for its SurgiBot robot-assisted surgery device, meaning the decision it had expected to come during the 1st quarter isn’t likely to happen until mid-April.
Research Triangle Park, N.C.-based TransEnterix claims SurgiBot as the 1st patient-side robotically enhanced laparoscopy platform, designed to be wheeled to a patient’s bedside and operate through a single port. In February the company said it had finalized the clearance application and expected a decision before the end of March. Read more
1. What do medical sales reps like most about their jobs?
Although medical sales reps report that relationships with patients and providers are the things they like best about their jobs, those who say they’re least satisfied with their jobs are also the ones who make the least, according to a survey of more than 1,400 reps.
Some 21% of respondents list “relationships with provides and patients” as the thing they like most about their jobs; only 6% said “money.” Sixteen percent listed “autonomy/flexibility” as their favorite thing, with 12% citing “ability to make an impact.” Read more
The post MassDevice.com +5 | The top 5 medtech stories for March 25, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1XT4dBD
Cap comentari:
Publica un comentari a l'entrada